Evercore ISI Group Maintains In-Line on Healthpeak Properties, Lowers Price Target to $22
Evercore ISI Group analyst James Kammert maintains Healthpeak Properties (NYSE:DOC) with a In-Line and lowers the price target from $23 to $22.
Stocks · News reference
Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields
In uncertain markets, investors turn to dividend-yielding stocks. Benzinga provides latest analyst ratings & news for high-yielding stocks.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Jefferies Assumes Healthpeak Properties at Hold, Lowers Price Target of $21
Jefferies analyst Joe Dickstein assumes Healthpeak Properties (NYSE:DOC) with a Hold rating and lowers Price Target of $21.
Barclays Maintains Equal-Weight on Healthpeak Properties, Raises Price Target to $24
Barclays analyst Richard Hightower maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight and raises the price target from $23 to $24.
8-K filing — GETTY REALTY CORP /MD/ (GTY)
Filed: 2026-09-28 AccNo: 0001193125-26-403487 Size: 205 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Keybanc Reiterates Overweight on Getty Realty, Maintains $36 Price Target
Citizens Reiterates Market Outperform on Getty Realty, Maintains $39 Price Target